Diversity of human papillomavirus in the anal canal of HIV-positive and HIV-negative men.


Journal

The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424

Informations de publication

Date de publication:
01 2021
Historique:
received: 10 08 2020
revised: 28 10 2020
accepted: 24 11 2020
pubmed: 1 12 2020
medline: 24 4 2021
entrez: 30 11 2020
Statut: ppublish

Résumé

To characterize the HPV diversity in the anal mucosa of men with different sexual behavior and HIV status by next-generation sequencing (NGS). Anal swabs from HIV-positive (n = 94; mean age, 38 years) and HIV-negative (n = 100; mean age, 37.5 years) men who have sex with men (MSM) and HIV-negative men (predominantly men who have sex with women, MSW) (n = 99; mean age, 38.2 years) were analyzed by broad-spectrum PCR protocols combined with NGS. Alpha HPV types (n = 74) were detected mainly in the MSM groups (HPV6, 11, and 43 were the most abundant types) compared with MSW (n = 16) (HPV11, 32, and 87 were among the most abundant). In contrast, beta HPVs were more abundantly detected among MSW (n = 45) than in the HIV-positive (n = 16) and HIV-negative (n = 26) MSM groups. Gamma HPVs were detected almost equally in HIV-positive MSM (n = 62), HIV-negative MSM (n = 58), and MSW (n = 57). In addition, 31 putative novel PV types were identified. Our data show that beta and gamma HPV types are present in the anal mucosa, thus reinforcing the existing evidence that they can be detected at anatomical sites other than skin. Alpha and beta HPV distribution among these three groups appears to vary according to sexual behavior.

Sections du résumé

BACKGROUND
To characterize the HPV diversity in the anal mucosa of men with different sexual behavior and HIV status by next-generation sequencing (NGS).
METHODS
Anal swabs from HIV-positive (n = 94; mean age, 38 years) and HIV-negative (n = 100; mean age, 37.5 years) men who have sex with men (MSM) and HIV-negative men (predominantly men who have sex with women, MSW) (n = 99; mean age, 38.2 years) were analyzed by broad-spectrum PCR protocols combined with NGS.
FINDINGS
Alpha HPV types (n = 74) were detected mainly in the MSM groups (HPV6, 11, and 43 were the most abundant types) compared with MSW (n = 16) (HPV11, 32, and 87 were among the most abundant). In contrast, beta HPVs were more abundantly detected among MSW (n = 45) than in the HIV-positive (n = 16) and HIV-negative (n = 26) MSM groups. Gamma HPVs were detected almost equally in HIV-positive MSM (n = 62), HIV-negative MSM (n = 58), and MSW (n = 57). In addition, 31 putative novel PV types were identified.
CONCLUSIONS
Our data show that beta and gamma HPV types are present in the anal mucosa, thus reinforcing the existing evidence that they can be detected at anatomical sites other than skin. Alpha and beta HPV distribution among these three groups appears to vary according to sexual behavior.

Identifiants

pubmed: 33253726
pii: S0163-4453(20)30725-8
doi: 10.1016/j.jinf.2020.11.030
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112-116

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest Dr Giuliano has received compensation for her role as a consultant and member of Merck & Co., Inc. Advisory Boards. Her institution has received funding for research. No conflicts of interest are declared for any other authors.

Auteurs

Luisa Galati (L)

International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France.

Rosario N Brancaccio (RN)

International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France.

Purnima Gupta (P)

International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France.

Eugenie Lohmann (E)

International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France.

Alexis Robitaille (A)

International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France.

Racheal S Dube Mandishora (RSD)

International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France; Department of Medical Microbiology, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.

Cyrille Cuenin (C)

International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France.

Raffaele Filotico (R)

Dermatologia Oncologica, IRCCS G. Paolo II, Istituto Tumori, Bari, Italy.

Jean-Damien Combes (JD)

International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France.

Anna R Giuliano (AR)

Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, Tampa, FL, USA.

Maria Gabriella Donà (MG)

STI/HIV Unit, San Gallicano Dermatological Institute IRCCS, Rome, Italy.

Massimo Tommasino (M)

International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France. Electronic address: tommasinom@iarc.fr.

Tarik Gheit (T)

International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France. Electronic address: gheitt@iarc.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH